The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia

被引：0
|
作者：
Pirker, T. [1 ]
Keys, T. [1 ]
Pham, T. [2 ]
Montecillo, J. [1 ]
Byers, M. [1 ]
Adamson, P. [1 ]
Richards, A. M. [1 ]
Pemberton, C. [1 ]
机构：
[1] Univ Otago Christchurch, Christchurch, New Zealand
[2] Univ Auckland, Auckland, New Zealand
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.3657
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Elevated soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients
    Lippi, Giuseppe
    Henry, Brandon M.
    Favaloro, Emmanuel J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (11) : E413 - E415
  • [32] The value of urinary soluble urokinase plasminogen activator receptor (suPAR) in children with nephrotic syndrome
    Phuong Anh Le Thy
    Kiem Hao Tran
    Thuy Yen Hoang Thi
    Minh Phuong Phan Thi
    Huu Son Nguyen
    AIMS MEDICAL SCIENCE, 2021, 8 (02): : 163 - 174
  • [33] Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia
    T. Mölkänen
    E. Ruotsalainen
    C. W. Thorball
    A. Järvinen
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1417 - 1424
  • [34] Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease
    Kolho, Kaija-Leena
    Valtonen, Elsa
    Rintamaki, Hanne
    Savilahti, Erkki
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (8-9) : 951 - 955
  • [35] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42
  • [36] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [37] Soluble urokinase plasminogen activator receptor (suPAR) for the prediction of ventilator-associated pneumonia (VAP)
    van Oort, Pouline M. P.
    Bos, Lieuwe D.
    Povoa, Pedro
    Ramirez, Paula
    Torres, Antonio
    Artigas, Antonio
    Schultz, Marcus J.
    Martin-Loeches, Ignacio
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [38] Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia
    Molkanen, T.
    Ruotsalainen, E.
    Thorball, C. W.
    Jarvinen, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) : 1417 - 1424
  • [39] Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals
    Chew-Harris, Janice
    Appleby, Sarah
    Richards, A. Mark
    Troughton, Richard W.
    Pemberton, Christopher J.
    CLINICAL BIOCHEMISTRY, 2019, 69 : 36 - 44
  • [40] Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments
    Morten Alstrup
    Jeppe Meyer
    Martin Schultz
    Line Jee Hartmann Rasmussen
    Lars Simon Rasmussen
    Lars Køber
    Jakob Lundager Forberg
    Jesper Eugen-Olsen
    Kasper Iversen
    World Journal of Surgery, 2019, 43 : 780 - 790
12345